<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04447339</url>
  </required_header>
  <id_info>
    <org_study_id>ISI-RoNSM-01</org_study_id>
    <nct_id>NCT04447339</nct_id>
  </id_info>
  <brief_title>Open Nipple Sparing Mastectomy (NSM)</brief_title>
  <acronym>NSM Open</acronym>
  <official_title>A Retrospective, Multicenter Study of Open Nipple Sparing Mastectomy (NSM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intuitive Surgical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intuitive Surgical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is retrospective, multicenter chart review is to evaluate the complication rates of&#xD;
      prophylactic open NSM procedures through 42 days postoperatively&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is retrospective, multicenter chart review is to evaluate the complication rates of&#xD;
      prophylactic open NSM procedures through 42 days postoperatively&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety Endpoint: complication rate</measure>
    <time_frame>IntraOperative period through 42 days postoperatively</time_frame>
    <description>To assess the number of open nipple sparing mastectomy complications compared to the number of procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>IntraOperative period through 42 days postoperatively</time_frame>
    <description>Ability to completely excise and preserve Nipple Areola Complex</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Nipple Sparing Mastectomy</condition>
  <arm_group>
    <arm_group_label>Open</arm_group_label>
    <description>Prophylactic NSM cases by Open approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nipple Sparing Mastectomy</intervention_name>
    <description>Prophylactic open NSM procedures</description>
    <arm_group_label>Open</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive subjects that have undergone open NSM procedures for prophylaxis between&#xD;
        January 1 2018 through 42 days prior to IRB approval will be included in this retrospective&#xD;
        chart review.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All female patients that have undergone open prophylactic NSM cases performed between&#xD;
        January 1, 2018 through 42 days prior to IRB approval&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ann Virk</last_name>
    <phone>408-523-4758</phone>
    <email>Ann.Virk@intusurg.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ann Virk</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NorthShore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katherine Kopkash, MD</last_name>
    </contact>
    <investigator>
      <last_name>Katherine Kopkash, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Massachusetts</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James W Jacob</last_name>
    </contact>
    <investigator>
      <last_name>James W Jacob, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Queens</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Kadison, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alan Kadison, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ari Brooks</last_name>
    </contact>
    <investigator>
      <last_name>Ari Brooks, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univ. of Texas MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa F Hwang, MD, FACS</last_name>
    </contact>
    <investigator>
      <last_name>Rosa F Hwang, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 16, 2020</study_first_submitted>
  <study_first_submitted_qc>June 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2020</study_first_posted>
  <last_update_submitted>May 15, 2021</last_update_submitted>
  <last_update_submitted_qc>May 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

